Cargando…
De Novo Human Angiotensin-Converting Enzyme 2 Decoy NL-CVX1 Protects Mice From Severe Disease After Severe Acute Respiratory Syndrome Coronavirus 2 Infection
The emergence of novel variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) underscores the need to investigate alternative approaches to prevent infection and treat patients with coronavirus disease 2019. Here, we report the preclinical efficacy of NL-CVX1, a de novo decoy that...
Autores principales: | Rebelo, Maria, Tang, Cong, Coelho, Ana R, Labão-Almeida, Carlos, Schneider, Matthias M, Tatalick, Laurie, Ruivo, Pedro, de Miranda, Marta Pires, Gomes, Andreia, Carvalho, Tânia, Walker, Matthew J, Ausserwoeger, Hannes, Pedro Simas, J, Veldhoen, Marc, Knowles, Tuomas P J, Silva, Daniel-Adriano, Shoultz, David, Bernardes, Gonçalo J L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503951/ https://www.ncbi.nlm.nih.gov/pubmed/37279654 http://dx.doi.org/10.1093/infdis/jiad135 |
Ejemplares similares
-
131. Antiviral NL-CVX1 Efficiently Blocks Infection of SARS-CoV-2 Viral Variants of Concern (VOC)
por: Su, Wen, et al.
Publicado: (2021) -
Interaction of severe acute respiratory syndrome-coronavirus and NL63 coronavirus spike proteins with angiotensin converting enzyme-2
por: Mathewson, Alison C., et al.
Publicado: (2008) -
Endemic SARS-CoV-2 will maintain post-pandemic immunity
por: Veldhoen, Marc, et al.
Publicado: (2021) -
Synthesis and Biological Evaluation of Homogeneous Thiol‐Linked NHC*‐Au‐Albumin and ‐Trastuzumab Bioconjugates
por: Matos, Maria J., et al.
Publicado: (2018) -
DecoyFinder, a tool for finding decoy molecules
por: Adrià, Cereto Massagué, et al.
Publicado: (2012)